Search results for "Peptide fragment"

showing 10 items of 356 documents

Ontogeny of bradykinin B2 receptors in the rat kidney: Implications for segmental nephron maturation

1997

Ontogeny of bradykinin B 2 receptors in the rat kidney: Implications for segmental nephron maturation. Kinins modulate renal function, yet their role in the developing kidney is largely unknown. To explore the developmental role of the kallikrein-kinin system, we examined the postnatal ontogeny and intrarenal localization of B 2 receptors in the rat. Northern blot analysis and RT-PCR documented the expression of B 2 receptor mRNA in the kidney and extrarenal tissues of fetal, neonatal and adult animals. The abundance of B 2 receptor mRNA is 10- to 30-fold higher in neonatal than adult tissues in the following order: kidney > heart > aorta > lung > brain. Receptor autoradiography revealed a …

Malemedicine.medical_specialtyReceptor Bradykinin B2Receptor expressionMolecular Sequence DataBradykininNephronBiologyBradykininKidneyPolymerase Chain ReactionRats Sprague-Dawleychemistry.chemical_compoundParacrine signallingInternal medicinemedicineAnimalsTissue DistributionAmino Acid SequenceRNA MessengerNorthern blotReceptorBradykinin Receptor AntagonistsDNA PrimersKidneyBase Sequenceurogenital systemReceptors BradykininGene Expression Regulation DevelopmentalNephronsKininImmunohistochemistryPeptide FragmentsRatsmedicine.anatomical_structureEndocrinologyAnimals NewbornchemistryNephrologyAutoradiographyKidney International
researchProduct

Food intake in lean and obese mice after peripheral administration of glucagon-like peptide 2

2012

We investigated the potential anorectic action of peripherally administered glucagon-like peptide 2 (GLP2) in lean and diet-induced obese (DIO) mice. Mice, fasted for 16 h, were injected i.p. with native GLP2 or [Gly2]GLP2, stable analog of GLP2, before or after GLP2 (3–33), a GLP2 receptor (GLP2R) antagonist, or exendin (9–39), a GLP1R antagonist. Food intake was measured at intervals 1, 2, 4, 8, and 24 h postinjection. In addition, we tested in lean mice the influence of [Gly2]GLP2 on gastric emptying and the effects of GLP1 alone or in combination with [Gly2]GLP2 on food intake. [Gly2]GLP2 dose dependently and significantly inhibited food intake in lean and DIO mice. The reduction of foo…

Malemedicine.medical_specialtyTime FactorsEndocrinology Diabetes and MetabolismPeptideDiet High-FatSettore BIO/09 - FisiologiaGlucagon-Like Peptide-1 ReceptorEatingMiceEndocrinologyGLP-2 food intake diet induced obesityGlucagon-Like Peptide 1Internal medicineAppetite DepressantsGlucagon-Like Peptide 2Receptors GlucagonmedicineAnimalsObesityReceptorchemistry.chemical_classificationDose-Response Relationship DrugGastric emptyingAntagonistReceptor Cross-TalkGlucagon-like peptide-2Peptide FragmentsMice Inbred C57BLDose–response relationshipEndocrinologyGastric EmptyingchemistryGlucagon-Like Peptide-2 ReceptorAnorecticGlucagon-Like Peptide-2 Receptor
researchProduct

Serum Neprilysin and Recurrent Admissions in Patients With Heart Failure

2017

Background Our aim was to evaluate the association between the soluble form of neprilysin ( sNEP ) levels and long‐term all‐cause, cardiovascular, and acute heart failure ( AHF ) recurrent admissions in an ambulatory cohort of patients with heart failure. sNEP has emerged as a new biomarker with promising implications for prognosis and therapy in patients with heart failure. Reducing the recurrent admission rate of heart failure patients has become an important target of public health planning strategies. Methods and Results We measured sNEP levels in 1021 consecutive ambulatory heart failure patients. End points were the number of all‐cause, cardiovascular, and AHF hospitalizations during…

Malemedicine.medical_specialtyTime Factorsmedicine.drug_class030204 cardiovascular system & hematologyPatient Readmissionneprilysin03 medical and health sciences0302 clinical medicinePredictive Value of TestsRisk FactorsInterquartile rangeCause of DeathInternal medicineNatriuretic Peptide BrainmedicineNatriuretic peptideHumans030212 general & internal medicineAgedOriginal ResearchAged 80 and overHeart Failurereadmissionbusiness.industryIncidenceMiddle AgedPrognosismedicine.diseasePeptide FragmentsConfidence intervalUp-RegulationQuartileSpainHeart failureCohortAmbulatoryCardiologyBiomarker (medicine)FemaleNeprilysinCardiology and Cardiovascular MedicinebusinessReadmissionBiomarkers
researchProduct

Comparison of Carbohydrate Antigen 125 and N-Terminal Pro-Brain Natriuretic Peptide for Risk Prediction After Transcatheter Aortic Valve Implantation

2017

Elevated carbohydrate antigen 125 (CA125) and N-terminal pro-brain natriuretic peptide (NTproBNP) have been associated with adverse outcome after transcatheter aortic valve implantation (TAVI). This study performs a comparison of both biomarkers for prognosis after TAVI. The study includes 363 patients. The primary end point was all-cause death or readmission for worsening congestive heart failure within 1 year after TAVI, and this end point occurred in 16% of the population. The optimal cutoff to predict the primary end point was 18.4 U/ml for CA125 and 2,570 ng/L for NTproBNP. Elevated CA125 levels were present in 52% and were associated with a higher rate of the primary end point (27% vs…

Malemedicine.medical_specialtyTranscatheter aorticmedicine.drug_classPopulation030204 cardiovascular system & hematologyRisk AssessmentTranscatheter Aortic Valve Replacement03 medical and health sciences0302 clinical medicinePredictive Value of TestsGermanyInternal medicineNatriuretic Peptide BrainNatriuretic peptideClinical endpointHumansMedicine030212 general & internal medicineeducationAged 80 and overHeart Failureeducation.field_of_studybusiness.industryAortic Valve StenosisPrognosismedicine.diseasePeptide FragmentsCA-125 AntigenPredictive value of testsHeart failureCardiologyFemaleCardiology and Cardiovascular MedicinebusinessCarbohydrate antigenBiomarkersN-terminal pro-Brain Natriuretic PeptideThe American Journal of Cardiology
researchProduct

ANATOMICAL AND FUNCTIONAL OUTCOMES OF SYMPTOMATIC IDIOPATHIC VITREOMACULAR TRACTION

2016

To describe the natural history of eyes with symptomatic idiopathic vitreomacular traction (VMT).Retrospective multicenter study of 168 eyes with spectral-domain optical coherence tomography (SD-OCT) findings consistent with idiopathic VMT. All eyes were graded according to SD-OCT findings. Grade 1 was defined as incomplete cortical vitreous separation with foveal attachment. Grade 2 was defined as Grade 1 plus intraretinal cysts or clefts. Grade 3 was defined as Grade 2 plus a foveal detachment. All patients were followed for at least 6 months.There were 168 patients (51 men) with a mean age of 68.8 ± 10.7 years. Patients were followed for a mean of 22.7 ± 20.1 months. The mean duration of…

Malemedicine.medical_specialtyVisual acuitygenetic structuresRemission SpontaneousVisual AcuityTissue AdhesionsVitreomacular tractionVitreous Detachment03 medical and health scienceschemistry.chemical_compound0302 clinical medicineFibrinolytic AgentsRetinal DiseasesVitrectomyOphthalmologymedicineHumansMedical historyFibrinolysin030212 general & internal medicineMacular holeAgedRetrospective StudiesSlit Lampbusiness.industryOcriplasminGeneral MedicineRetinal Perforationsmedicine.diseasePeptide Fragmentseye diseasesSurgeryNatural historyOphthalmologychemistry030221 ophthalmology & optometryFemalesense organsmedicine.symptombusinessTomography Optical CoherenceNatural history studyFibrinolytic agentRetina
researchProduct

Comparison between CA125 and NT-proBNP for evaluating congestion in acute heart failure

2020

Abstract Background Carbohydrate antigen 125 (CA125) and B-type natriuretic peptides are surrogate markers of congestion in patients with acute heart failure (AHF). The aim of the study was to assess the association between CA125 and NT-proBNP and congestion parameters in patients with AHF. Methods and results Prospective multicentre observational study that included 191 patients hospitalised for AHF. We recorded the presence of pleural effusion, peripheral oedema and inferior vena cava (IVC) diameter during the first 24–48 h after admission and evaluated their independent association with CA125 concentrations and the amino-terminal fraction of pro-B-type natriuretic peptide (NT-proBNP). Th…

Malemedicine.medical_specialtyendocrine system diseasesmedicine.drug_classPleural effusionPeripheral edemaInferior vena cavaVentricular Function LeftInternal medicineNatriuretic Peptide BrainmedicineNatriuretic peptideHumansIn patientProspective StudiesAgedAged 80 and overHeart FailureEjection fractionbusiness.industryStroke VolumeMiddle AgedPrognosismedicine.diseasePeptide Fragmentsmedicine.veinHeart failureCardiologySerum ca125Femalemedicine.symptombusinessBiomarkersMedicina Clínica (English Edition)
researchProduct

Long-Term Structural and Functional Myocardial Adaptations in Healthy Living Kidney Donors: A Pilot Study

2015

Background and Aims Compensatory renal hypertrophy following unilateral nephrectomy (UNX) occurs in the remaining kidney. However, the long-Term cardiac adaptive process to UNX remains poorly defined in humans. Our goal was to characterize myocardial structure and function in living kidney donors (LKDs), approximately 12 years after UNX. Methods and Results Cardiac function and structure in 15 Italian LKDs, at least 5 years after UNX (median time from donation = 8.4 years) was investigated and compared to those of age and sex matched U.S. citizens healthy controls (n = 15). Standard and speckle tracking echocardiography (STE) was performed in both LKDs and controls. Plasma angiotensin II, a…

Malemedicine.medical_specialtylcsh:MedicinePilot Projectschemistry.chemical_compoundInternal medicineNatriuretic Peptide BrainLiving DonorsmedicineHumanslcsh:ScienceAldosteroneKidney transplantationAgedKidneyMultidisciplinaryAldosteronebusiness.industryAngiotensin IIMyocardiumlcsh:RMyocardial adaptations Kidney donorsCompensatory renal hypertrophyHeartMiddle AgedUnilateral nephrectomymedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareKidney TransplantationAngiotensin IIPeptide FragmentsStructure and functionCardiovascular physiologyCross-Sectional Studiesmedicine.anatomical_structureEndocrinologychemistryCardiologylcsh:QFemalebusinessSettore M-EDF/01 - Metodi E Didattiche Delle Attivita' MotorieAtrial Natriuretic FactorProcollagenResearch ArticlePLOS ONE
researchProduct

Analysis of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes

2009

Background The N-terminal portion of brain natriuretic peptide (NT-proBNP) has been identified as an indicator of prognosis in different cardiovascular diseases. The objective of this study was to determine the utility of measuring plasma NT-proBNP levels in patients with acute coronary syndromes. Methods and results We studied 66 patients admitted in our division for acute coronary syndromes. Patients underwent a venous blood sample within 24 h from the admission to determine NT-proBNP levels. Increasing plasma levels of NT-proBNP (in tertiles) was associated with a greater history of hypertension and current smoking, whereas biochemical parameters were associated with higher level of crea…

Malemedicine.medical_specialtymedicine.drug_classCreatineRisk AssessmentVentricular Dysfunction Leftchemistry.chemical_compoundPredictive Value of TestsRecurrenceNt-proBNP N-terminal pro-B-type natriuretic peptide acute coronary sydromeInternal medicineNatriuretic Peptide BrainmedicineNatriuretic peptideCreatine Kinase MB FormHumansIn patientHospital MortalityAcute Coronary SyndromeAgedInpatientsCreatininebiologybusiness.industryTroponin IGeneral MedicineLength of StayMiddle AgedPrognosisBrain natriuretic peptidePeptide FragmentschemistryCreatininePredictive value of testsCardiologybiology.proteinFemaleCreatine kinaseN terminal pro b type natriuretic peptideCardiology and Cardiovascular MedicinebusinessBiomarkersCoronary Artery Disease
researchProduct

Bio-profiling and bio-prognostication of chronic heart failure with mid-range ejection fraction.

2018

Abstract Background Recent ESC guidelines on heart failure (HF) have introduced a new phenotype based on left ventricular ejection fraction (LVEF), called the mid-range (HFmrEF). This phenotype falls between the classical reduced (HFrEF) and preserved (HFpEF) HF phenotypes. We aimed to characterize the HFmrEF biomarker profile and outcomes. Methods 1069 consecutive ambulatory patients were included in the study (age 66.2 ± 12.8 years); 800 with HFrEF (74.8%), 134 with HFmrEF (12.5%), and 135 with HFpEF (12.5%). We measured serum concentrations of N-terminal pro-brain natriuretic peptide (NT-proBNP), high-sensitivity troponin T (hs-TnT), soluble suppression of tumorigenicity (ST2), galectin-…

Malemedicine.medical_specialtymedicine.drug_classGalectin 3030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineTroponin TInternal medicineNatriuretic Peptide BrainNatriuretic peptidemedicineHumans030212 general & internal medicineSoluble transferrin receptorAgedAged 80 and overHeart FailureEjection fractionbiologyTroponin Tbusiness.industryHazard ratioStroke VolumeStroke volumeMiddle Agedmedicine.diseasePrognosisPeptide FragmentsDeathHeart failureChronic Diseasebiology.proteinCardiologyBiomarker (medicine)FemaleCardiology and Cardiovascular MedicinebusinessBiomarkersFollow-Up StudiesInternational journal of cardiology
researchProduct

Head-to-Head Comparison of the Incremental Predictive Value of The Three Established Risk Markers, Hs-troponin I, C-Reactive Protein, and NT-proBNP, …

2020

Risk stratification among patients with coronary artery disease (CAD) is of considerable interest to potentially guide secondary preventive therapies. Cardiac troponins as well as C-reactive protein (hsCRP) and natriuretic peptides have emerged as biomarkers for risk stratification. The question remains if one of these biomarkers is superior in predicting adverse outcomes. Thus, we perform a head-to-head comparison between high-sensitivity troponin I (hsTnI), hsCRP, and N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with CAD. Plasma levels were measured in a cohort of 2193 patients with documented CAD. The main outcome measures were cardiovascular (CV) death and/or nonfata…

Malemedicine.medical_specialtymedicine.drug_classHead to headMyocardial Infarctionlcsh:QR1-502030204 cardiovascular system & hematologyBiochemistryArticlelcsh:MicrobiologyCoronary artery disease03 medical and health sciences0302 clinical medicineInternal medicineNatriuretic Peptide BrainTroponin ImedicineNatriuretic peptideHumans030212 general & internal medicineMyocardial infarctioncardiovascular diseasesMolecular BiologyAgedbiologybusiness.industryhigh-sensitivity troponin ITroponin IC-reactive proteinHazard ratioMiddle Agedmedicine.diseasePeptide FragmentsN-terminal pro-brain natriuretic peptideC-Reactive ProteinCohortbiology.proteinCardiologyFemalehigh-sensitivity C-reactive proteinprognosisbusinessBiomarkerscoronary artery diseaseFollow-Up StudiesBiomolecules
researchProduct